BAP1 Tumour Predisposition Syndrome Due to Whole BAP1 Gene Deletion

Author:

Pandithan Dinusha1ORCID,Klebe Sonja2,McKavanagh Grace3,Rawlings Lesley4,Yu Sui4,Nicholl Jillian4,Poplawski Nicola15ORCID

Affiliation:

1. Adult Genetics Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia

2. Anatomical Pathology, SA Pathology and Flinders University, Flinders Medical Centre Site, Bedford Park, South Australia, Australia

3. Molecular Pathology, Mater Hospital Brisbane, South Brisbane, Australia

4. Genetics and Molecular Pathology, SA Pathology, Adelaide Site, South Australia, Australia

5. Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia

Abstract

BRCA-1-associated protein-1 (BAP1) tumour predisposition syndrome (BAP1-TPDS) is a dominant hereditary cancer syndrome. The full spectrum of associated malignancies is yet to be fully characterised. We detail the phenotypic features of the first reported family with a whole BAP1 gene deletion. This report also adds to the emerging evidence that the rhabdoid subtype of meningioma is a part of the clinical spectrum of this tumour predisposition syndrome.

Publisher

Hindawi Limited

Subject

General Medicine

Reference20 articles.

1. BAP1: role in carcinogenesis and clinical implications;D. A. Kobrinski;Translational Lung Cancer Research,2020

2. Gene of the month: BAP1;A. Wang;Journal of Clinical Pathology,2016

3. An adolescent with uveal melanoma and BAP1 tumor predisposition syndrome;K. Z. Young;JAAD Case Reports,2020

4. BRCA1-associated protein (BAP1)-inactivated melanocytic tumors;A. J. Zhang;Journal of Cutaneous Pathology,2019

5. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers;M. H. Abdel-Rahman;Journal of Medical Genetics,2011

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Hereditary cancer syndromes with increased risk of renal cancer;Cancer Urology;2023-11-16

2. BAP1 genetic testing among melanoma and cancer-prone families in Sweden;Acta Oncologica;2023-06-02

3. Family Matters: Germline Testing in Thoracic Cancers;American Society of Clinical Oncology Educational Book;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3